XIAP抑制在系统性硬化症中的作用
该研究探讨X连锁凋亡抑制蛋白(XIAP)在系统性硬化症(SSc)发病中的作用。发现XIAP在SSc和硬化性cGvHD成纤维细胞中表达增高,由TGF-β/SMAD3依赖方式诱导,并通过WNT/β-catenin信号放大促纤维化效应;靶向失活XIAP可改善小鼠纤维化模型。
要点
- XIAP在SSc和cGvHD皮肤成纤维细胞中表达增高,其他IAP家族成员未增高。
- TGF-β以SMAD3依赖方式诱导XIAP表达。
- 失活XIAP减少WNT诱导的成纤维细胞活化和胶原释放,改善小鼠纤维化。
核心结论
- XIAP是纤维化两个核心通路之间的新连接点,在SSc和cGvHD中过表达并放大WNT/β-catenin的促纤维化效应。
- 靶向失活XIAP可抑制SSc小鼠模型中成纤维细胞的异常活化。
研究设计与样本
- 分析SSc、慢性移植物抗宿主病(cGvHD)患者及健康个体皮肤样本中XIAP表达。
- 通过siRNA敲低和药理学抑制失活XIAP,在培养成纤维细胞及博来霉素、拓扑异构酶I(topoI)诱导和Wnt10b转基因小鼠纤维化模型中分析效应。
主要发现
- XIAP在SSc和硬化性cGvHD成纤维细胞中表达增高,其他凋亡抑制蛋白家族成员未增高。
- TGF-β以SMAD3依赖方式诱导XIAP表达。
- 失活XIAP减少WNT诱导的成纤维细胞活化和胶原释放。
- 抑制XIAP在耐受剂量下改善博来霉素、topoI及Wnt10b过表达诱导的纤维化。
- XIAP促纤维化效应通过WNT/β-catenin信号介导,失活XIAP以TLE依赖方式减少β-catenin与TCF结合。
临床怎么用
- XIAP可能作为SSc纤维化的潜在治疗靶点,但尚未进入临床推荐。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: X-linked inhibitor of apoptosis protein (XIAP) is a multifunctional protein with important functions in apoptosis, cellular differentiation and cytoskeletal organisation and is emerging as potential target for the treatment of various cancers. The aim of the current study was to investigate the role of XIAP in the pathogenesis of systemic sclerosis (SSc). METHODS: The expression of XIAP in human skin samples of patients with SSc and chronic graft versus host disease (cGvHD) and healthy individuals was analysed by quantitative PCR, immunofluorescence (IF) and western blot. XIAP was inactivated by siRNA-mediated knockdown and pharmacological inhibition. The effects of XIAP inactivation were analysed in cultured fibroblasts and in the fibrosis models bleomycin-induced and topoisomerase-I-(topoI)-induced fibrosis and in Wnt10b-transgenic mice. RESULTS: The expression of XIAP, but not of other inhibitor of apoptosis protein family members, was increased in fibroblasts in SSc and sclerodermatous cGvHD. Transforming growth factor beta (TGF-β) induced the expression of XIAP in a SMAD3-dependent manner. Inactivation of XIAP reduced WNT-induced fibroblast activation and collagen release. Inhibition of XIAP also ameliorated fibrosis induced by bleomycin, topoI and overexpression of Wnt10b in well-tolerated doses. The profibrotic effects of XIAP were mediated via WNT/β-catenin signalling. Inactivation of XIAP reduces binding of β-catenin to TCF to in a TLE-dependent manner to block WNT/β-catenin-dependent transcription. CONCLUSIONS: Our data characterise XIAP as a novel link between two core pathways of fibrosis. XIAP is overexpressed in SSc and cGvHD in a TGF-β/SMAD3-dependent manner and in turn amplifies the profibrotic effects of WNT/β-catenin signalling on fibroblasts via transducin-like enhancer of split 3. Targeted inactivation of XIAP inhibits the aberrant activation of fibroblasts in murine models of SSc.
引用
- Bergmann C, Hallenberger L, Chenguiti Fakhouri S, et al. X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc). Ann Rheum Dis. 2021. PMID: 33903093. doi:10.1136/annrheumdis-2020-219822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。